Natco Pharma has received successful Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at its drug formulations facility at Kothur Unit, Telangana, India, during the period Jan 16th - 24th, 2017. This Kothur formulation facility predominantly caters to regulated international markets, including USA.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.
